-
NHS proton beam centres aim to treat a “game-changing” 1,500 patients a year
Two new NHS proton beam centres have commenced construction with planners claiming they could treat 1,500 patients a year.
-
How the deadly Lassa and Ebola viruses could help destroy brain tumour cells
Deadly viruses are being combined with a cancer cell killing virus in trials aimed at destroying glioma brain tumours.
-
Children and young people survey extended
Our survey looking at quality of life issues in children, young people and families has been extended to ensure our findings have the biggest possible impact, we’d like closer to 500.
-
Tributes after Tasha loses brain tumour fight
Tributes have been paid to The Brain Tumour Charity’s ‘sassy and brave’ Young Ambassador Tasha Floyd, who has died at the age of 24.
-
New NICE guideline on brain tumours
We were recently pleased to hear that the National Institute for Health and Care Excellence (NICE) will be developing a new guideline on primary brain tumours and cerebral metastases.
-
Be a Star Christmas campaign launches
We’re aiming to tackle the issue of late diagnosis of brain tumours. For this to happen we’ve enlisted the support of researchers, GPs and our community, to drive awareness and effect change to diagnosis times. Spearheading this Christmas Campaign is Sophie O’Hagan.
-
Ten-year-old’s scan delay after brain tumour battle
Ewan MacKerracher, a ten year old boy from Coleraine, Northern Ireland, has been diagnosed twice in the past with brain tumours. He has been waiting almost two years for a routine scan that could show any recurrence of the disease.
-
China joins glioblastoma Australian clinical trial project
China joins GBM AGILE, an Australasian adaptive clinical trial project tackling glioblastoma multiforme.
-
Computer games can build memory skills and a sharper mind – could they help brain tumour patients?
From Call of Duty to Candy Crush, digital games are played by millions around the world. But could they offer more than entertainment?
-
American research identifies glioblastoma-limiting drug
Scientists from the Translational Genomics Research Institute have identified the drug propentofylline (PPF) that limits the protein TROY in glioblastoma (GBM) cells and that also increases the effectiveness of chemotherapy drug temozolomide and radiation to treat GBM.
-
Record-breaking rower pays tribute to team Ocean Valour
“Keep going because I promise you, you will succeed. Any dream you have, just smash it.”
-
Story of hope: Alice and Emma
In July 2015 Alice was discharged after nine years of treatment and monitoring for a brain tumour. Her mum Emma talks about what it means to get to the end of treatment.
-
Breakthrough in brain tumour liquid biopsy
A research team based in Catalonia, Spain, has pioneered a more accurate and less invasive liquid biopsy technique for brain tumours.
-
GM algae holds potential breakthrough in treating brain tumours
Australian researchers, coordinating with teams from Germany, have trialled genetically-modified algae loaded with chemotherapy drugs and found that they destroy 90% of cancer cells while leaving healthy ones intact.
-
You’re invited to our APPG on brain tumours
We would like to invite you to our meeting of the All-Party Parliamentary Group (APPG) on Brain Tumours.
-
Emergency diagnosis more likely for brain tumour patients
Brain tumour patients are more likely to be diagnosed via a hospital A&E department than those with any other type of tumour, new figures show.
-
Canadian scientists develop ‘game-changer’ blood-brain barrier treatment
Claiming to be a world’s first, Canadian scientists have used targeted ultrasound and microbubbles to deliver chemotherapy drugs directly into brain tumours.
-
Off-patent Drugs Bill blocked at House of Commons
The Off-patent Drugs Bill has been blocked at its second reading in the House of Commons despite support from MPs of both parties and a number of charities and health organisations. It will be put onto the agenda for another reading in December, however is unlikely to be allocated time for debate.
-
The American Brain Tumour Association awards $1million for innovative research
The American Brain Tumour Association (ABTA), founded in 1973 and based in Chicago, has announced it is awarding $1million in new research grants.
-
Protein discovery could lead to more effective treatment
Scientists have discovered a protein that is produced inside the blood vessels at the invasive edge of brain tumours.
-
Young Ambassador meets Caroline Lucas MP
One of our fantastic Young Ambassadors April Watkins recently met with Caroline Lucas, the country’s first Green Party MP in Brighton, where she was able to share details of our HeadSmart campaign and her personal experiences as a young adult going through treatment for a brain tumour.
-
Clinicians back Off-patent Drugs Bill
The potential benefit of the Off-patent Drugs Bill to people affected by a brain tumour has been highlighted in an editorial featured in The Telegraph. The paper also features a letter in support of The Bill signed by 40 clinicians including Professor Susan Short who is leading a clinical trial to investigate the effect of hydroxychloroquine on high grade gliomas undergoing radiotherapy.
-
Our response to the Accelerated Access Review
The interim report of the Accelerated Access Review, a UK Government review looking at ways to speed up patient access to new drugs, was published on the 27th October.
-
Latest figures reveal where people live could influence cancer diagnosis times
Cancer Research UK have released some figures that demonstrate how getting a cancer diagnosis in a timely manner varies across the UK.